查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511808

牙周病治疗药物市场规模、份额、趋势分析报告：依疾病、药物类型、通路、地区、细分市场预测，2024-2030年

Periodontal Therapeutics Market Size, Share & Trends Analysis Report By Disease, By Drug Type, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

牙周病治疗药物市场成长及趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球牙周药物市场规模预计将达到14.1亿美元，2024年至2030年复合年增长率为7.2%。

这个市场主要是由于老年人口增加而导致牙周病盛行率不断上升所推动的。根据NCBI 2023年9月发表的报导，预计受这种疾病影响的老年人比例将从2020年的42.44%上升到2050年的54.57%。预计轻度牙周病仍是最常见的，占80.39%。此外，2020 年至 2050 年间，未经治疗的蛀牙数量预计将增加 75.2%。

人们对口腔健康的认识不断提高正在推动市场成长。利用形成性需求评估的资料进行了许多宣传活动，以关注不同人群牙齿健康状况不佳这一更广泛的问题。这些倡议旨在提高人们对牙周健康的认识和知识，促进自我护理预防性牙科行为，并鼓励利用牙科保健服务。有些宣传活动是针对特定人口群体的，例如成人、儿童、婴幼儿父母以及被认为牙齿问题风险较高的社会经济弱势群体。挪威的 Perio Year宣传活动旨在提高 15 岁及以上人群的意识提升。作为宣传活动的一部分，牙医接受了一年的培训，以在患者就诊期间强化宣传活动的讯息。该宣传活动利用各种媒体管道，并向杂货店、药房和牙科诊所分发资讯手册。

与牙周病相关的抗生素抗药性细菌的出现需要一些重要的行动和考虑。例如，2022 年 10 月，一项重点评估与牙周病相关的微生物的抗菌药物抗药性的研究强调了继续研究以了解这些细菌的抗药性程度的重要性。这项研究强调需要开发标靶治疗和策略来有效解决抗菌素抗药性。这项研究强调了医疗保健专业人员不加区别地开抗生素处方对抗菌素抗药性的有害影响。这凸显了遵守正确治疗方案的重要性以及医疗保健专业人员了解他们所处理的细菌的抗药性模式的必要性。

此外，巨量资料挖掘、系统生物学和深度学习方法的整合对药物开发的技术进步产生了重大影响。这些进展旨在促进新药的发现和开发，用于治疗以牙龈和牙周组织发炎和感染为特征的疾病。一个重要的方法是利用巨量资料挖掘来分析全基因组微阵列资料集，例如 GSE10334资料集，其中包括来自中度至重度牙周炎患者的资料。这种方法能够识别疾病过程中涉及的候选基因、蛋白质-蛋白质相互作用 (PPIN) 网络和调控网络 (GRN)。透过应用系统识别和系统顺序检测方法，研究人员可以为患病和健康对照组确定真正的全基因表现网络（GWGEN）。这一步骤对于阐明疾病的分子机制和确定药物开发的潜在标靶至关重要。

牙周病治疗药物市场报告亮点

  • 2023年，慢性牙周病细分市场占最大市场。这是由于患者明显不适导致治疗率高、治疗依从率高、盛行率整体上升。
  • 2023年，多西环素药物主导市场。强力霉素已被证明可以抑制基质金属蛋白酶 8 (MMP-8)，这种酶通常与牙周炎有关，即使浓度较低。
  • 2023年医院药局分销管道占最大市场份额。该细分市场的成长是由医院的高处方率、患者对从医院药房购买处方药的高偏好以及因牙周病到医院就诊的患者的增加所推动的。
  • 由于先进的医疗基础设施、疾病盛行率上升以及有利的法规环境等因素，北美在市场上占据主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章牙周病治疗市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 牙周病治疗药物市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章牙周病治疗药物市场：疾病估计与趋势分析

  • 全球牙周病治疗药物市场：特定疾病仪表板
  • 全球牙周病治疗药物市场：依疾病区分的波动分析
  • 全球牙周病治疗药物市场：依疾病和收益
  • 牙龈炎
  • 慢性牙周病
  • 进行性牙周病
  • 其他的

第五章牙周病治疗药物市场：药物种类预估及趋势分析

  • 全球牙周药物市场：按药物类型分類的仪表板
  • 全球牙周病治疗药物市场：依药物类型波动分析
  • 全球牙周病药物市场：依药物类型和收益
  • 强力霉素
  • 米诺四环素
  • 洛赫西定
  • 甲硝唑
  • 其他的

第六章牙周病治疗药物市场：通路估算及趋势分析

  • 全球牙周病药物市场：按分销管道分類的仪表板
  • 全球牙周病治疗药物市场：依通路波动分析
  • 全球牙周病治疗药物市场：依通路及收益
  • 医院药房
  • 零售药房
  • 线上管道

第七章 牙周病治疗药物市场：按疾病、药物类型和分销管道分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Pfizer Inc.
    • Lupin Ltd
    • Teva Pharmaceuticals USA, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Tokyo Chemical Industry Co., Ltd.
    • Bausch Health Companies Inc.
    • USAntibiotics
    • Melinta Therapeutics LLC
    • Cipla, Inc.
    • Chartwell Pharmaceuticals LLC.
Product Code: GVR-4-68040-295-7

Periodontal Therapeutics Market Growth & Trends:

The global periodontal therapeutics market size is anticipated to reach USD 1.41 billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing prevalence of periodontal diseases aided by the growing geriatric population. According to an article published by NCBI, in September 2023, the percentage of older adults affected by the disease is anticipated to rise from 42.44% in 2020 to 54.57% by 2050. Mild periodontal diseases are predicted to continue being the most common type, accounting for 80.39% of cases. Additionally, the number of untreated cavities in teeth is expected to increase by 75.2% between 2020 and 2050.

Increasing awareness about oral health fuels the growth of the market. Numerous campaigns have been created using data from formative needs assessments, focusing on the widespread issue of poor dental health in various populations. These initiatives aimed to increase awareness and knowledge about periodontal health, promote self-care dental preventive behaviors, and encourage the utilization of dental health services. Certain campaigns were tailored to specific demographics, including adults, children, parents of infants, and disadvantaged socio-economic groups considered to be at higher risk for dental problems. The Perio-Year Campaign in Norway targeted individuals aged 15 and above to increase awareness. As part of the initiative, dentists received one year of training to reinforce campaign messages during patient consultations. The campaign utilized diverse media channels and distributed informational booklets to grocery stores, pharmacies, and dental offices.

The emergence of antibiotic-resistant strains of bacteria associated with periodontal diseases necessitates several key actions and considerations. For instance, in October 2022, a research study focused on assessing antimicrobial resistance in microorganisms associated with periodontal diseases underscores the importance of ongoing research in understanding the scope of resistance among these bacteria. This investigation highlights the necessity for developing targeted treatments and strategies to address antibiotic resistance effectively.The study emphasizes the detrimental impact of healthcare professionals on antimicrobial resistance due to indiscriminate prescribing of antimicrobials. This emphasizes the significance of adhering to appropriate prescribing practices and the necessity for healthcare providers to possess awareness regarding the resistance patterns of the bacteria they are addressing.

Furthermore, technological advancements in drug development have been significantly influenced by the integration of big data mining, systems biology, and deep learning methods. These advancements aim to enhance the discovery and development of novel drugs for the treatment of the diseases, which are characterized by inflammation and infection in the gums and periodontal tissues. One key methodology involves leveraging big data mining to analyze genome-wide microarray datasets, such as the GSE10334 dataset, which contains data from individuals with moderate to severe periodontitis. This approach enables the identification of candidate genes, protein-protein interaction (PPIN) networks, and regulatory networks (GRNs) involved in the disease process. Applying system identification and system order detection methods, researchers can pinpoint genuine gene-wide gene expression networks (GWGENs) for both diseased and healthy control groups. This step is crucial for elucidating the molecular mechanisms underlying the disease and identifying potential targets for drug development.

Periodontal Therapeutics Market Report Highlights:

  • The chronic periodontal disease segment held the largest share of the market in 2023. It can be attributed to the high treatment rate of the disease due to significant discomfort to the patients, high treatment adherence rate, and overall, a growing prevalence of the disease.
  • The doxycycline drug type dominated the market in 2023. Doxycycline, even at lower concentrations, has been found to inhibit matrix metalloproteinase-8 (MMP-8), an enzyme abundant in periodontitis.
  • Hospital pharmacies distribution channel held the largest share of the market in 2023. The high prescription rates at hospitals, high patient preference of purchase prescribed medications from hospital pharmacies, and increasing number of patients visiting hospitals for periodontal diseases are driving the growth of this segment.
  • North America dominated the market owing to factors such as advanced healthcare infrastructure, rising prevalence of the disease, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Drug Type
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease and Drug Type outlook
    • 2.2.2. Distribution Channel outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Periodontal Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of periodontal diseases
      • 3.2.1.2. Increasing awareness about oral health
      • 3.2.1.3. Rising geriatric population
      • 3.2.1.4. Technological advancements in dentistry
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited awareness and education for oral health
      • 3.2.2.2. Stringent regulatory policies
  • 3.3. Periodontal Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Periodontal Therapeutics Market: Disease Estimates & Trend Analysis

  • 4.1. Global Periodontal Therapeutics Market: Disease Dashboard
  • 4.2. Global Periodontal Therapeutics Market: Disease Movement Analysis
  • 4.3. Global Periodontal Therapeutics Market by Disease, Revenue
  • 4.4. Gingivitis
    • 4.4.1. Gingivitis market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Chronic Periodontal Disease
    • 4.5.1. Chronic Periodontal Disease market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Aggressive Periodontal Disease
    • 4.6.1. Aggressive Periodontal Disease market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Periodontal Therapeutics Market: Drug Type Estimates & Trend Analysis

  • 5.1. Global Periodontal Therapeutics Market: Drug Type Dashboard
  • 5.2. Global Periodontal Therapeutics Market: Drug Type Movement Analysis
  • 5.3. Global Periodontal Therapeutics Market by Drug Type, Revenue
  • 5.4. Doxycycline
    • 5.4.1. Doxycycline market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Minocycline
    • 5.5.1. Minocycline market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Chlorhexidine
    • 5.6.1. Chlorhexidine market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Metronidazole
    • 5.7.1. Metronidazole market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Other drug types
    • 5.8.1. Other drug types market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Periodontal Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Periodontal Therapeutics Market: Distribution Channel Dashboard
  • 6.2. Global Periodontal Therapeutics Market: Distribution Channel Movement Analysis
  • 6.3. Global Periodontal Therapeutics Market by Distribution Channel, Revenue
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Online Channel
    • 6.6.1. Online Channel market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Periodontal Therapeutics Market: Regional Estimates & Trend Analysis by Disease, Drug Type, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Pfizer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Lupin Ltd
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Teva Pharmaceuticals USA, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sun Pharmaceutical Industries Ltd.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Tokyo Chemical Industry Co., Ltd.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Bausch Health Companies Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. USAntibiotics
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Melinta Therapeutics LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Cipla, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Chartwell Pharmaceuticals LLC.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 4 North America periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 5 North America periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 7 U.S. periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 8 U.S. periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Canada periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 10 Canada periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 11 Canada periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Europe periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 14 Europe periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 15 Europe periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16 Germany periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 17 Germany periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 18 Germany periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 UK periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 20 UK periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 21 UK periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 23 France periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 24 France periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Italy periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 26 Italy periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 27 Italy periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Spain periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 29 Spain periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 30 Spain periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Denmark periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 32 Denmark periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 33 Denmark periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Sweden periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 35 Sweden periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 36 Sweden periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Norway periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 38 Norway periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 39 Norway periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 China periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 45 China periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 46 China periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Japan periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 48 Japan periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 49 Japan periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 India periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 51 India periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 52 India periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 South Korea periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 54 South Korea periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 55 South Korea periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Australia periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 57 Australia periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 58 Australia periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 Thailand periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 60 Thailand periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 61 Thailand periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 64 Latin America periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 65 Latin America periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66 Brazil periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 67 Brazil periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 68 Brazil periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 Mexico periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 70 Mexico periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 71 Mexico periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 73 Argentina periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 74 Argentina periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75 MEA periodontal therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 77 MEA periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 78 MEA periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 80 South Africa periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 81 South Africa periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 UAE periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 86 UAE periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 87 UAE periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait periodontal therapeutics market, by Disease, 2018 - 2030 (USD Million)
  • Table 89 Kuwait periodontal therapeutics market, by drug type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait periodontal therapeutics market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 periodontal therapeutics market: market outlook
  • Fig. 14 Periodontal Therapeutics competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 periodontal therapeutics market driver impact
  • Fig. 18 periodontal therapeutics market restraint impact
  • Fig. 19 periodontal therapeutics market: Disease movement analysis
  • Fig. 20 periodontal therapeutics market: Disease outlook and key takeaways
  • Fig. 21 Gingivitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Chronic Periodontal Disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Aggressive Periodontal Disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 periodontal therapeutics market: Drug Type movement analysis
  • Fig. 26 periodontal therapeutics market: Drug Type outlook and key takeaways
  • Fig. 27 Doxycycline market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Minocycline market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chlorhexidine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Metronidazole market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other drug types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 periodontal therapeutics market: Distribution Channel movement analysis
  • Fig. 33 periodontal therapeutics market: Distribution Channel outlook and key takeaways
  • Fig. 34 Hospital Pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Retail Pharmacies estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Online Channel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Global periodontal therapeutics market: Regional movement analysis
  • Fig. 38 Global periodontal therapeutics market: Regional outlook and key takeaways
  • Fig. 39 Global periodontal therapeutics market share and leading players
  • Fig. 40 North America, by country
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK key country dynamics
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany key country dynamics
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France key country dynamics
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain key country dynamics
  • Fig. 56 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark key country dynamics
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Sweden key country dynamics
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Norway key country dynamics
  • Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 China key country dynamics
  • Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Japan key country dynamics
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 India key country dynamics
  • Fig. 69 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand key country dynamics
  • Fig. 71 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea key country dynamics
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Australia key country dynamics
  • Fig. 75 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Brazil key country dynamics
  • Fig. 78 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Mexico key country dynamics
  • Fig. 80 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Argentina key country dynamics
  • Fig. 82 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Market share of key market players - periodontal therapeutics market